Statistics about Health, Pharma & Medtech in United States
Statistics
- Lixte Biotechnology Holdings, Inc. liabilities 2014-2016
- Lisata Therapeutics, Inc. revenue 2014-2023
- Solid Biosciences liabilities 2019-2023
- Sonnet Biotherapeutics Holdings, Inc. net income 2015-2019
- Solid Biosciences revenue 2018-2022
- Lisata Therapeutics, Inc. total assets 2019-2023
- Ardelyx gross profit 2015-2019
- Ardelyx net income 2016-2020
- Landos Biopharma net income 2020-2023
- Sonoma Pharmaceuticals revenue 2019-2023
- Summit Therapeutics revenue 2019-2023
- Lenz Therapeutics net cash 2020-2023
- Ardelyx revenue 2019-2023
- Lenz Therapeutics total assets 2020-2023
- Lenz Therapeutics total equity 2019-2023
- Lenz Therapeutics operating profit 2020-2023
- Lenz Therapeutics net income 2020-2023
- Ardelyx total assets 2019-2023
- Lenz Therapeutics liabilities 2020-2023
- Ladrx total assets 2019-2023
- Ladrx liabilities 2019-2023
- Lisata Therapeutics, Inc. net cash 2019-2023
- Anaptysbio total equity 2019-2023
- Ladrx total equity 2019-2023
- Ladrx net cash 2019-2023
- Ardelyx total equity 2019-2023
- Lisata Therapeutics, Inc. total equity 2019-2023
- Lixte Biotechnology Holdings, Inc. operating profit 2019-2023
- Karyopharm Therapeutics liabilities 2019-2023
- Hcw Biologics net cash 2020-2023
- Jounce Therapeutics, Inc. net cash 2018-2022
- Janux Therapeutics total equity 2019-2023
- Halozyme Therapeutics, Inc. net cash 2019-2023
- Halozyme Therapeutics, Inc. revenue 2019-2023
- Jounce Therapeutics, Inc. total assets 2018-2022
- Janux Therapeutics total assets 2020-2023
- Halozyme Therapeutics, Inc. total assets 2019-2023
- Halozyme Therapeutics, Inc. total equity 2019-2023
- Halozyme Therapeutics, Inc. liabilities 2022-2023
- Halozyme Therapeutics, Inc. operating profit 2019-2023
- Kala Bio net income 2019-2023
- Janux Therapeutics net cash 2020-2023
- Jounce Therapeutics, Inc. liabilities 2018-2022
- Gilead Sciences net cash 2019-2023
- Gilead Sciences total assets 2019-2023
- Jounce Therapeutics, Inc. operating profit 2018-2022
- Gilead Sciences operating profit 2019-2023
- Janux Therapeutics liabilities 2020-2023
- Janux Therapeutics operating profit 2020-2023
- Gilead Sciences total equity 2019-2023
- Jasper Therapeutics net income 2020-2022
- Jounce Therapeutics, Inc. total equity 2018-2022
- Janux Therapeutics net income 2020-2023
- Societal Cdmo revenue 2019-2023
- Jasper Therapeutics operating profit 2020-2023
- Sunshine Biopharma, Inc net income 2017-2021
- Societal Cdmo total assets 2019-2023
- Societal Cdmo net cash 2017-2023
- Societal Cdmo liabilities 2019-2023
- Kaya Holdings gross profit 2019-2023
- Kiora Pharmaceuticals Inc revenue 2017-2021
- Societal Cdmo net income 2019-2023
- Karyopharm Therapeutics revenue 2019-2023
- Societal Cdmo operating profit 2019-2023
- Kaya Holdings net income 2019-2023
- Kaleido Biosciences, Inc. revenue 2020-2021
- Kaya Holdings revenue 2019-2023
- Kalvista Pharmaceuticals revenue 2015-2019
- Kintara Therapeutics net income 2020-2024
- Kala Bio revenue 2019-2023
- Kiora Pharmaceuticals Inc net income 2014-2017
- Karyopharm Therapeutics net income 2019-2023
- Kinnate Biopharma Inc. net income 2020-2023
- Kalvista Pharmaceuticals net income 2019-2023
- Janux Therapeutics revenue 2020-2023
- Korro Bio, Inc. liabilities 2019-2023
- Alx Oncology Holdings liabilities 2019-2023
- Intra-Cellular Therapies total equity 2019-2023
- Invitae liabilities 2018-2022
- Intellia Therapeutics operating profit 2019-2023
- Invitae operating profit 2018-2022
- Intellia Therapeutics liabilities 2022-2023
- Intellia Therapeutics revenue 2019-2023
- Intellia Therapeutics net income 2019-2023
- Johnson & Johnson total equity 2022-2023
- Jaguar Health total equity 2016-2020
- Innovation1 Biotech total equity 2019-2023
- Intellia Therapeutics total assets 2019-2023
- International Stem Cell total equity 2019-2023
- Spyre Therapeutics, Inc. net cash 2019-2023
- Spyre Therapeutics, Inc. total equity 2019-2023
- Spyre Therapeutics, Inc. liabilities 2019-2023
- Johnson & Johnson total assets 2019-2023
- Spyre Therapeutics, Inc. net income 2018-2022
- Spyre Therapeutics, Inc. total assets 2019-2023
- Spyre Therapeutics, Inc. revenue 2019-2023
- Lipella Pharmaceuticals total assets 2021-2023
- Invitae revenue 2018-2022
- Intellia Therapeutics net cash 2019-2023
- Korro Bio, Inc. net income 2019-2023